Pharmaceuticals, Biotechnology and Life Sciences
Advancing discoveries by providing scientists with high-quality disease-state biospecimens to support preclinical and clinical research LOS ANGELES & GLASGOW, Scotland–(BUSINESS…
PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CEO?src=hash" target="_blank"gt;#CEOlt;/agt;–Xcovery Holdings, Inc., an oncology-focused biopharmaceutical company, today announced the appointment of Li Mao,…
IRVINE, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24NVUS&src=ctag" target="_blank"gt;$NVUSlt;/agt; lt;a href="https://twitter.com/hashtag/otitismedia?src=hash" target="_blank"gt;#otitismedialt;/agt;–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc. (NASDAQ: VXRT), a clinical stage biotechnology company developing oral recombinant vaccines that are administered…
SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AACR19?src=hash" target="_blank"gt;#AACR19lt;/agt;–Adaptive Biotechnologies and its collaborators will present 11 studies, including an oral presentation and 10 poster presentations,…
– Signs agreement focusing on exploring insurance coverage for medical cannabis Canada wide – TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc.…
Blinded, randomized, placebo-controlled, 40-week extension trial, TRCA-301E, met its primary and all secondary endpoints, supporting the long-term safety and efficacy…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug…
Global distribution deals signed in Europe and China, including Can-Fite’s largest deal to date for up to $74.5 M Top-line…
Webcast Today at 8:00 am Eastern Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the…